Ditetradecylamin | Cas 17361-44-3
Product specifications
IUPAC name: N-tetradecyl-1-tetradecanamine
Cas: 17361-44-3
Synonyms: Ditetradecylamin; N-tetradecyltetradecan-1-amine; 1-Tetradecanamine,N-tetradecyl; N-Tetradecyl-1-tetradecanamine
Chemical formula:C28H59N
MW: 409.77 g/mol
Price & Availability
| Cat nr | Stock | Quantity | Price |
|---|---|---|---|
| 240607-1 | In stock | 1 g | €65 |
| 240607-10 | In stock | 10 g | €250 |
The novel chelator lipid 3(nitrilotriacetic acid)-ditetradecylamine (NTA(3)-DTDA) promotes stable binding of His-tagged proteins to liposomal membranes: potent anti-tumor responses induced by simultaneously targeting antigen, cytokine and costimulatory signals to T cells
The PubMed article with the ID 16225839 focuses on the involvement of mitochondrial and nuclear DNA mutations in the aging process and the development of neurodegenerative diseases. The study emphasizes how both types of DNA mutations can contribute to the decline in cellular function seen with aging and the progression of conditions like Alzheimer’s and Parkinson’s diseases.
Mitochondrial DNA mutations affect the energy production in cells, leading to increased oxidative stress and cellular damage. On the other hand, nuclear DNA mutations disrupt various cellular processes, contributing further to cellular dysfunction. The study highlights the importance of understanding these genetic changes to develop therapeutic strategies aimed at mitigating the effects of aging and treating neurodegenerative diseases.
For more detailed information, you can access the article: https://pubmed.ncbi.nlm.nih.gov/16225839/